Business Description
Nuvation Bio Inc
NAICS : 541713
SIC : 2834
ISIN : US67080N1019
Description
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 171.63 | |||||
| Equity-to-Asset | 0.97 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.04 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.25 | |||||
| 9-Day RSI | 38.04 | |||||
| 14-Day RSI | 36.52 | |||||
| 6-1 Month Momentum % | -4.6 | |||||
| 12-1 Month Momentum % | -16.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 47.51 | |||||
| Quick Ratio | 47.51 | |||||
| Cash Ratio | 47.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -0.15 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -13.78 | |||||
| ROA % | -13.39 | |||||
| ROIC % | -1571.14 | |||||
| ROC (Joel Greenblatt) % | -2273.26 | |||||
| ROCE % | -16.1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.49 | |||||
| Price-to-Tangible-Book | 0.49 | |||||
| EV-to-EBIT | 3.12 | |||||
| EV-to-Forward-EBIT | -0.12 | |||||
| EV-to-EBITDA | 3.13 | |||||
| EV-to-FCF | 4.16 | |||||
| Price-to-Net-Current-Asset-Value | 0.49 | |||||
| Price-to-Net-Cash | 0.49 | |||||
| Earnings Yield (Greenblatt) % | 32.05 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:NUVB
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nuvation Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.41 | ||
| Beta | 0 | ||
| Volatility % | 48.4 | ||
| 14-Day RSI | 36.52 | ||
| 14-Day ATR ($) | 0.083802 | ||
| 20-Day SMA ($) | 1.519 | ||
| 12-1 Month Momentum % | -16.58 | ||
| 52-Week Range ($) | 1.18 - 2.545 | ||
| Shares Outstanding (Mil) | 218.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nuvation Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nuvation Bio Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nuvation Bio Inc Frequently Asked Questions
What is Nuvation Bio Inc(NUVB)'s stock price today?
The current price of NUVB is $1.39. The 52 week high of NUVB is $2.55 and 52 week low is $1.18.
When is next earnings date of Nuvation Bio Inc(NUVB)?
The next earnings date of Nuvation Bio Inc(NUVB) is 2023-11-03 Est..
Does Nuvation Bio Inc(NUVB) pay dividends? If so, how much?
Nuvation Bio Inc(NUVB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers